The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clinical outcomes

Objective: Endometrial cancer (EC) shows substantial heterogeneity in their immune microenvironment. BHLHE22 is consistently hypermethylated in EC and high expression of BHLHE22 is likely to be immunosuppressive in the tumor microenvironment. Herein, we evaluated expression of BHLHE22, programmed ce...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Taiwanese Journal of Obstetrics & Gynecology
المؤلفون الرئيسيون:	Lin-Yu Chen, Hsing-Yu Chen, Hung-Cheng Lai, Shiou-Fu Lin, Kuo-Chang Wen, Darmawi, Phui-Ly Liew
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2025-01-01
الموضوعات:	BHLHE22 Endometrial cancer PD-L1 Survival Tumor-infiltrating immune cells
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S1028455924002857